To access this element change to forms mode OFF
Grant Award View - GA217908
Improving clinical outcomes for children and adults with bronchiectasis:...
GA ID:
GA217908
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2027
Value (AUD):
$2,069,492.72
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
Improving clinical outcomes for children and adults with bronchiectasis: a multi-centre randomised controlled trial using a novel mucolytic with a discovery biomarker
Purpose:
We plan a study that looks at a novel therapy, erdosteine, for children/young adults with bronchiectasis (BE). Our study addresses several unmet needs as they are no current therapies (other than antibiotics) for children with BE. Our goal is to improve the outcomes of children/young adults with BE by using erdosteine and understanding underlying causes and contributors to acute disease flare-ups. Our study, informed by consumers, will improve the future outcomes of people with BE if successful.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2014419
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Queensland University of Technology
Recipient ABN:
83 791 724 622
Grant Recipient Location
Suburb:
Brisbane City
Town/City:
Brisbane City
Postcode:
4000
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, QLD, NT, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, MALAYSIA